Converting hemodialysis patients from intravenous paricalcitol to intravenous doxercalciferol – a dose equivalency and titration study

Patients can be managed safely and effectively with conversion and dose titration from paricalcitol to doxercalciferol. Both conversion strategies maintained iPTH at clinically satisfactory levels. Furthermore, doxercalciferol therapy resulted in drug acquisition cost-savings.